|
|
|
|
|
|
|
28.05.25 - 23:03
|
Jeff Jochims Appointed Executive Chair at Genesee Scientific (Business Wire)
|
|
|
Seasoned Life Sciences Executive to Guide Accelerated GrowthSAN DIEGO--(BUSINESS WIRE)--Genesee Scientific, a leading provider of laboratory essentials for the life sciences industry, is pleased to announce the elevation of Jeff Jochims' role to Executive Chair of the Board. Jochims has served as a member of Genesee's Board of Directors since 2023 and has over 25 years of executive leadership experience in healthcare and life sciences distribution.
“Jeff's deep industry expertise and strategic vision make him an exceptional fit for Genesee Scientific at this critical stage of our growth,” said Dan Monahan, CEO. “His track record in scaling operational excellence and commercial strategy in life sciences distribution will be invaluable as we expand our impact across research and diagnostic markets.”
Jochims has held prominent executive leadership roles at Thermo Fisher Scientific and Owens & Minor and currently serves as Chief Executive Officer at I2Pure. His appointment signals Genesee Scientifi...
|
|
|
|
|
|
|
08.05.25 - 12:36
|
Owens & Minor Reports First Quarter 2025 Financial Results (Business Wire)
|
|
|
Top-Line Growth Led by the Patient Direct Segment
Patient Direct Operating Margin Expanded by 173 Basis Points
Company Reaffirmed 2025 Financial Guidance
Remain Actively Engaged in Potential Sale of Products & Healthcare Services Segment
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2025.
“Across the business we continued to see strong execution and progress towards our near and long-term strategies. Patient Direct delivered mid-single digit top-line growth with strong performance in nearly all therapy categories led by Diabetes and Sleep Supplies. The top-line growth combined with strong operational execution delivered mid-teen expansion in EBITDA for the segment. Our Products & Healthcare Services segment saw top-line growth in our Medical Distribution division, as well as good progress on driving profit improvement initiatives. We remain actively engaged in the sale process of our Products & Healthcare Services s...
|
|
|
|
|
01.05.25 - 12:36
|
Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call (Business Wire)
|
|
|
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2025 on Thursday, May 8, 2025, before trading begins on the New York Stock Exchange.
The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917.
All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26.03.25 - 21:45
|
Owens & Minor Announces Launch of Senior Secured Notes Offering (Business Wire)
|
|
|
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE:OMI) (the “Company”) announced today that it has launched a private offering (the “Offering”) of $600 million aggregate principal amount of senior secured notes due 2030 (the “Notes”), subject to customary and market conditions.
Unless the previously announced acquisition (the “Acquisition”) of Rotech Healthcare Holdings Inc. (“Rotech”) is consummated concurrently with or promptly following the closing of the Offering, the Company will deposit the gross proceeds from the Offering into a segregated escrow account until the date that certain escrow release conditions, including the consummation of the Acquisition, have been satisfied. The consummation of the Acquisition is subject to customary closing conditions.
The Notes will be fully and unconditionally guaranteed, jointly and severally, on a senior secured basis by the Company and certain domestic subsidiaries of the Company that guarantee the Company's existing term loan fac...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
